Trials / Terminated
TerminatedNCT05844826
Evaluation of the Microbiome in Multiple Sclerosis
A Clinical Study To Evaluate Small Intestine Microbiome In Multiple Sclerosis (MS)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Nimble Science Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
To access the small intestinal microbiome and find abnormal microbiome/metabolome signature in luminal fluid samples from small bowel in MS compared to HC that could be used as biomarkers for MS.
Detailed description
Participants will be swallowing the SIMBA capsule which allows for minimally-invasive sampling of the microbiome and metabolome deep in the small intestine. Researchers will use the capsule samples to access the small intestinal microbiome and find abnormal metabolomic signatures in luminal fluid samples from the small bowel in Multiple Sclerosis (MS) patients compared to healthy control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SIMBA Capsule | Participants will swallow capsule |
Timeline
- Start date
- 2023-06-26
- Primary completion
- 2024-04-24
- Completion
- 2024-04-24
- First posted
- 2023-05-06
- Last updated
- 2025-05-15
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05844826. Inclusion in this directory is not an endorsement.